Atrandi Biosciences raised $25M in a Series A funding round led by Lux Capital to develop new products based on its semi-permeable capsule technology.
Amount Raised
$25 Million
Round Type
Series A
VilniusBiotechnologyLife ScienceInvestors
Description
Atrandi Biosciences has raised $25 million in a Series A funding round led by Lux Capital, with participation from several other investors. The company plans to use the funds to develop new products based on its semi-permeable capsule technology and establish an office in Boston to better serve its U.S. customers.
Quick answer
Atrandi Biosciences raised $25 Million in a Series A round, dated February 20, 2025. Investors: Crids Capital, Vsquared Ventures, Practica Capital, Metaplanet and Lux Capital. Atrandi Biosciences is based in Vilnius, Vilnius County, Lithuania.
- How much did Atrandi Biosciences raise?
- Atrandi Biosciences raised $25 Million in a Series A round on February 20, 2025.
- Who invested in Atrandi Biosciences?
- Crids Capital, Vsquared Ventures, Practica Capital, Metaplanet and Lux Capital are named as investors in this round.
- What does Atrandi Biosciences do?
- Atrandi Biosciences is transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology, enabling scalable, true single-cell multiomics.
- Where is Atrandi Biosciences based and how big is it?
- Atrandi Biosciences is based in Vilnius, Vilnius County, Lithuania. Fundz records about 59 employees.
- Who are the decision-makers at Atrandi Biosciences?
- Fundz holds 1 contact at Atrandi Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Life Science and Biotechnology around the same time
Companies in the same sectors as Atrandi Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Treysta Medical Technologies raised $93K (Pre-Seed) on April 4, 2025.
- Astek Diagnostics raised $750K (Series A) on April 4, 2025.
- Exobiosphere raised $2.2M (Seed) on April 4, 2025.
- RayThera raised $110M (Series A) on April 4, 2025.
- FOXO Technologies raised $325K (Seed) on April 4, 2025.
- Perkant Tech raised $772K (Seed) on April 3, 2025.
Who to call at Atrandi Biosciences, and when
A new round usually means Atrandi Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Atrandi Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atrandi Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atrandi Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atrandi Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAtrandi Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.